Factors Associated With Progression-free Survival, Overall Survival in the Treatment of Burkitt Lymphoma

Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses the factors associated with progression-free survival and overall survival in the treatment of Burkitt lymphoma.

Pharmacy Times interviewed Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, to discuss his SOHO 2021 conference presentation on prognostication and treatment of Burkitt lymphoma in the modern era.

During the interview, Olszewski discussed the factors associated with progression-free survival and overall survival in the treatment of Burkitt lymphoma.

Related Videos
Conference attendees watching a speaker | Image credit: kasto - stock.adobe.com
Biosimilars | Image credit: lexiconimages - stock.adobe.com
Medical care team | Image credit: Iryna - stock.adobe.com
Pharmacist helping patient | Image credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist in home infusion environment | Image credit: Satjawat - stock.adobe.com
Medical science laboratory | Image credit: alphaspirit - stock.adobe.com
Pharmacist managing inventory | Image credit: StratfordProductions - stock.adobe.com
Pharmacists talking with a nurse | Image credit: Jacob Lund - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.